Literature DB >> 12194382

Diagnosis and treatment of Wilson's disease.

G J Brewer1, J K Fink, P Hedera.   

Abstract

Wilson's disease is due to an inherited defect in copper excretion into the bile by the liver. The resulting copper accumulation and copper toxicity results in liver disease, and in some patients, brain damage. Patients present, generally between the ages of 10 and 40 years, with liver disease, neurological disease of a movement disorder type, or behavioral abnormalities, and often with a combination of these. Because Wilson's disease is effectively treated, it is extremely important for physicians to learn to recognize and diagnose the disease. Treatment options have evolved rapidly in the last few years, with zinc now being the drug of choice in most situations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 12194382     DOI: 10.1055/s-2008-1040842

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  16 in total

Review 1.  Clinical management of Wilson disease.

Authors:  Peter Hedera
Journal:  Ann Transl Med       Date:  2019-04

Review 2.  Insights into the management of Wilson's disease.

Authors:  Mohmadshakil Kathawala; Gideon M Hirschfield
Journal:  Therap Adv Gastroenterol       Date:  2017-10-03       Impact factor: 4.409

3.  Movement Disorder in Copper Toxicity Rat Model: Role of Inflammation and Apoptosis in the Corpus Striatum.

Authors:  Jayantee Kalita; Vijay Kumar; Usha K Misra; Himangsu K Bora
Journal:  Neurotox Res       Date:  2019-12-06       Impact factor: 3.911

4.  Proton MR spectroscopy in Wilson disease: analysis of 36 cases.

Authors:  Leandro T Lucato; Maria Concepción G Otaduy; Egberto R Barbosa; Alexandre A C Machado; Alexander McKinney; Luiz A Bacheschi; Milberto Scaff; Giovanni G Cerri; Claudia C Leite
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

5.  Copper Induces Apoptosis of Neuroblastoma Cells Via Post-translational Regulation of the Expression of Bcl-2-family Proteins and the tx Mouse is a Better Model of Hepatic than Brain Cu Toxicity.

Authors:  Hsien W Chan; Tianbing Liu; Giuseppe Verdile; Glenda Bishop; Ryan J Haasl; Mark A Smith; George Perry; Ralph N Martins; Craig S Atwood
Journal:  Int J Clin Exp Med       Date:  2008-01-20

Review 6.  Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.

Authors:  George J Brewer
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

7.  Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy.

Authors:  Jayantee Kalita; Vijay Kumar; Abhay Ranjan; Usha K Misra
Journal:  Neuromolecular Med       Date:  2015-07-30       Impact factor: 3.843

8.  A Study on Apoptosis and Anti-apoptotic Status in Wilson Disease.

Authors:  J Kalita; V Kumar; U K Misra
Journal:  Mol Neurobiol       Date:  2015-12-08       Impact factor: 5.590

9.  Rare presentation of Wilson's disease: a case report.

Authors:  Vikram Kalra; Sandeep Mahajan; Pawan Kumar Kesarwani
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

10.  Diffusion tensor imaging (DTI) and its clinical correlates in drug naïve Wilson's disease.

Authors:  Rakesh Jadav; Jitender Saini; Sanjib Sinha; Bhavanishankara Bagepally; S Rao; Arun B Taly
Journal:  Metab Brain Dis       Date:  2013-05-01       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.